Osteoarthritis and Bone Disorders News

Intra-articular injections of autologous adipose-derived stem cells or adipose-derived stromal vascular fraction significantly improve pain and function in knee osteoarthritis, according to data published in Arthritis Research & Therapy.

SAN DIEGO — Establishing mandatory competencies for musculoskeletal ultrasound is necessary to improve its use in both rheumatology residency programs and clinical practice, a speaker said at ACR Convergence 2023.

Adults with Graves’ disease do not have an increased risk for an osteoporosis-related fracture later in life compared with those without Graves’ disease, according to data from a retrospective study published in Thyroid.

Patients with osteoarthritis who undergo arthroscopic partial meniscectomy appear to demonstrate greater OARSI score progression via osteophytes, but not Kellgren-Lawrence grades, according to data published in Arthritis Care & Research.

For patients with diseases such as lupus or rheumatoid arthritis who take low-dose drugs at lower frequencies, the relief afforded by over-the-counter drugs such as ibuprofen and naproxen can be a boon.

Patients with osteoarthritis who experience neck pain lasting longer than 1 year have a significant increased risk for all-cause mortality, according to data published in Arthritis Research & Therapy.

Patients with rheumatoid arthritis or osteoarthritis in rural areas are less likely to report in-person health care use, including physician visits and diagnostic tests, vs. those in urban areas, according to data.

Among older adults enrolled in an osteoarthritis cohort, those with foot symptoms such as pain and stiffness demonstrated a higher risk for death vs. those without foot symptoms, according to data published in Arthritis Care & Research.

Patients with intra-articular mineralization demonstrate a two-times higher likelihood of having frequent knee pain, as well as more intermittent or constant pain, according to data published in Arthritis & Rheumatology.

EP-104AR, an injectable form of fluticasone propionate designed slowly distribute through the knee joint and provide pain relief for up to 6 months, improved pain vs. a placebo over 12 weeks, according to the manufacturer.